Netherlands· NL-34f328de6614
Segluromet 7,5 mg/850 mg filmomhulde tabletten
A metformin and ertugliflozin product containing ertugliflozine-l-pyroglutaminezuur + metforminehydrochloride, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Metformin and ertugliflozin is registered in 8 of 19 countries.
Countries holding a registration under ATC A10BD23 (metformin and ertugliflozin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Metformin and ertugliflozin · ATC A10BD23
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ERTUGLIFLOZINE-L-PYROGLUTAMINEZUUR + METFORMINEHYDROCHLORIDE
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Netherlands (NL)
- ATC code
- A10BD23
- ATC class
- Metformin and ertugliflozin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/18/1265
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BD23
Metformin and ertugliflozin, as other registers publish it.
- PolandSeglurometMerck Sharp & Dohme B.V.
- PolandSeglurometMerck Sharp & Dohme B.V.
- DenmarkSeglurometMerck Sharp & Dohme B.V.
- FinlandSeglurometMerck Sharp & Dohme B.V.
- FinlandSeglurometMerck Sharp & Dohme B.V.
- FinlandSeglurometMerck Sharp & Dohme B.V.
- DenmarkSeglurometMerck Sharp & Dohme B.V.
- PolandSeglurometMerck Sharp & Dohme B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa05bb23-d9b7-4f60-8f21-9c428a39101d GET /v1/drugs/fa05bb23-d9b7-4f60-8f21-9c428a39101d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/segluromet-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Metformin and ertugliflozin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120630",
"excipients": [
"CARNAUBAWAS (E 903)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSPOVIDON (E 1202)",
"HYPROLOSE (E 463)",
"HYPROMELLOSE (E 464)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"IJZEROXIDE ZWART (E 172)",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMLAURILSULFAAT",
"POVIDON K 30 (E 1201)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"ERTUGLIFLOZINE-L-PYROGLUTAMINEZUUR",
"METFORMINEHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2018/03/23",
"procedure_number": "EMEA/H/C/004314",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/18/1265",
"additional_monitoring": "N"
}See everything about metformin and ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.